We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant

12 hedge funds and large institutions have $123K invested in Revelation Biosciences Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

29% less funds holding

Funds holding: 1712 (-5)

41% less capital invested

Capital invested by funds: $208K → $123K (-$85K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

REVBW Hedge Fund Activity: Q3 2022 in Review

12 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2022, worth a combined $123K — down 41% from $208K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of REVBW and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Linden Advisors, adding an estimated $30.7K. The largest seller was Walleye Capital, exiting entirely with an estimated $9K sold.

  • 12 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2022, down from 17 in Q2 2022.
  • Funds reported $123K of Revelation Biosciences Warrant stock for Q3 2022, down 41% quarter-over-quarter.
  • 0 funds opened new Revelation Biosciences Warrant positions in Q3 2022 and 5 closed out, a net change of -5 holders.
  • The largest Revelation Biosciences Warrant buyer in Q3 2022 was Linden Advisors, an estimated $30.7K added.
  • The largest Revelation Biosciences Warrant seller in Q3 2022 was Walleye Capital, an estimated $9K sold.

Based on aggregated 13F filings for Q3 2022.